Related Experiment Videos
Reversible selective beta(2)-adrenoceptor agonist-induced myopathy
Rheumatology (Oxford, England)
|January 17, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Does spontaneous cartilage thickening occur in osteoarthritic knees? Data from IMI-APPROACH and the OAI.
Osteoarthritis and cartilage·2025
Greater pain and functional impairment in chronic erosive hand osteoarthritis compared to treated rheumatoid arthritis: A comparative study.
Osteoarthritis and cartilage open·2025
Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis.
Osteoarthritis and cartilage·2024
Pain-phenotyping in osteoarthritis: Current concepts, evidence, and considerations towards a comprehensive framework for assessment and treatment.
Osteoarthritis and cartilage open·2024
Free IL-18 in NLRC4-associated autoinflammatory disease without macrophage activation syndrome.
Rheumatology (Oxford, England)·2026
Examining the role of dipeptidyl peptidase IV (DPPIV) in psoriatic disease.
Rheumatology (Oxford, England)·2026
Systemic juvenile idiopathic arthritis: are there any predictors of disease course?
Rheumatology (Oxford, England)·2026
Assessing the mortality burden after acute myocardial infarction in systemic lupus erythematosus: insights from the MINAP Registry.
Rheumatology (Oxford, England)·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026